More than seven million TikTok users have watched a clip posted by dad Ashley “Twist” Glazebrook (@ashleytwistglazebrook) ...

Eli Lilly has signed a heavily backloaded agreement to license a gamma-secretase modulator treatment for Alzheimer's disease from AlzeCure Pharma for up to $1 billion biobucks. Lilly is obtaining the ...

The company is using that money to plan for the future. Eli Lilly has been making strategic acquisitions, mostly outside of its core area of expertise. Thanks to these deals, it has bolstered its ...

Eli Lilly's Jacob Van Naarden says Lilly is using the financial strength from its GLP-1 drugs like Mounjaro and Zepbound to fund its new dealmaking strategy. Van Naarden recently became Lilly's head ...

Aryna Sabalenka put in the hard work to win her second round at 2026 Roland Garros on Thursday. Now she’s ready to dance. Draped in Material Good diamonds, The world No. 1 edged through a tricky first ...

Eli Lilly has splashed up to $3.8 billion on an infectious disease pipeline, acquiring Curevo, LimmaTech Biologics and Vaccine Company to extend its buying spree into viral and bacterial pathogen R&D.

Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. Eli Lilly said Tuesday it would buy ...

TikTok is doing everything it can to convince people that it’s an ecommerce platform. First came TikTok Shop in 2023, and then came GMV Max, an automated ads solution to optimize ROI for TikTok Shop.

Eli Lilly said on Monday it would buy privately held cancer drug developer Ajax Therapeutics for up to $2.3 billion in cash, as the U.S. drugmaker looks to expand its oncology pipeline. Lilly has been ...

Lily Faught has always loved to dance. The now 17-year-old Williamson County girl started dancing at the Dance Mania Nashville studio when she was five, but she said she always had aspirations of ...

Eli Lilly (LLY) on Monday announced an agreement to acquire Kelonia Therapeutics, a privately held cancer drug developer, in a deal worth up to $7B in cash, confirming a prior report from The Wall ...

Eli Lilly & Co.’s Zepbound is helping to solve one of the most intractable health challenges of our time: obesity. Now, the drugmaker is taking on another significant public health predicament: sleep ...